文献速递关节外科

全髋关节置换术前一年髋骨关节炎的医疗成本分析

What Are the Costs of Hip Osteoarthritis in the Year Prior to a Total Hip Arthroplasty?
PubMed 文献 · J Arthroplasty · 2019-09-19

该研究利用Humana行政索赔数据库,分析接受择期初次全髋关节置换术的Medicare Advantage和商业保险受益人在术前一年的医疗资源利用与成本。结果显示,术前一年人均费用为MA 512美元、商业保险764美元,其中办公室就诊和止痛药物占比最大,保守治疗占总成本的40%-44%。

要点

  • 术前一年人均费用:MA 512美元,商业保险764美元。
  • 办公室就诊占总成本比例最高:商业保险35%,MA 41%。
  • 保守治疗(注射、理疗、止痛药)占术前一年总成本的40%-44%。

核心结论

  • 全髋关节置换术前一年,髋骨关节炎相关护理平均每人花费500-800美元。
  • 尽管存在潜在风险,阿片类药物和类固醇注射在术前最后3个月仍常被使用。

研究设计与样本

  • 使用Humana行政索赔数据库识别接受择期初次全髋关节置换术的Medicare Advantage和商业保险受益人。
  • 将术前一年医疗资源利用分为办公室就诊、X线、磁共振成像、计算机断层扫描、关节内类固醇和透明质酸注射、物理治疗和止痛药物等类别。
  • 报告总1年成本和每患者平均报销金额。

主要发现

  • MA受益人总1年术前成本为21,022,883美元(平均512美元/患者),商业保险受益人为4,481,401美元(平均764美元/患者)。
  • 办公室就诊占总1年成本比例最大:商业保险35%,MA 41%。
  • 止痛药物占比次之:商业保险28%,MA 35%。
  • 保守治疗(类固醇注射、透明质酸注射、物理治疗和止痛药物)单独占术前1年总成本的40%-44%。
  • 术前最后3个月阿片类药物和类固醇注射的医疗利用较高。

关键数值与推荐

  • MA受益人术前1年总成本21,022,883美元,平均512美元/患者。
  • 商业保险受益人术前1年总成本4,481,401美元,平均764美元/患者。
  • 办公室就诊成本占比:商业保险35%,MA 41%。
  • 止痛药物成本占比:商业保险28%,MA 35%。
  • 保守治疗占总成本40%-44%。

临床怎么用

  • 全髋关节置换术前一年,髋骨关节炎相关护理人均花费500-800美元。
  • 术前最后3个月阿片类药物和类固醇注射使用频繁。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The majority of the cost analysis literature on total hip arthroplasties (THAs) has been focused around the perioperative and postoperative period, with preoperative costs being overlooked. METHODS: The Humana Administrative Claims database was used to identify Medicare Advantage (MA) and Commercial beneficiaries undergoing elective primary THAs. Preoperative healthcare resource utilization in the year prior to a THA was grouped into the following categories: office visits, X-rays, magnetic resonance imagings, computed tomography scans, intra-articular steroid and hyaluronic acid injections, physical therapy, and pain medications. Total 1-year costs and per-patient average reimbursements for each category have been reported. RESULTS: Total 1-year preoperative costs amounted to $21,022,883 (average = $512/patient) and $4,481,401 (average = $764/patient) for MA and Commercial beneficiaries, respectively. The largest proportion of total 1-year costs was accounted for by office visits (35% in Commercial; 41% in MA) followed by pain medications (28% in Commercial; 35% in MA). Conservative treatments (steroid injections, hyaluronic acid injections, physical therapy, and pain medications) alone accounted for 40%-44% of the total 1-year costs prior to a THA. A high healthcare utilization within the last 3 months prior to surgery was noted for opioids and steroid injections. CONCLUSION: On average, $500-$800/patient is spent on hip osteoarthritis-related care in the year prior to a THA. Despite their potential risks, opioids and steroid injections are often utilized in the last 3 months prior to surgery.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Malik AT, Alexander JH, Li DD, et al. What Are the Costs of Hip Osteoarthritis in the Year Prior to a Total Hip Arthroplasty? J Arthroplasty. 2019. PMID: 31601455. doi:10.1016/j.arth.2019.09.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。